David Krempa Eton Pharmaceuticals, Inc. (ETON) insider trading activity

ETON Quotes by TradingView

David Krempa is Chief Business Officer of Eton Pharmaceuticals, Inc.. Currently has a direct ownership of 630,238 shares of ETON, which is worth approximately $10.7 Million. The most recent transaction as insider was on Jan 14, 2026, when has been sold 1,942 shares (Common Stock) at a price of $15.62 per share, resulting in proceeds of $30,334. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 630K
2.87% 3M change
n/a 12M change
Total Value Held $10.7 Million

David Krempa Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 14 2026
SELL
Payment of exercise price or tax liability
$30,334 $15.62 p/Share
1,942 Reduced 0.31%
630,238 Common Stock
Dec 12 2025
SELL
Payment of exercise price or tax liability
$106,488 $17.0 p/Share
6,264 Reduced 0.98%
632,180 Common Stock
Jun 16 2025
SELL
Open market or private sale
$150,584 $14.73 p/Share
10,223 Reduced 1.64%
612,646 Common Stock
Jun 13 2025
SELL
Open market or private sale
$100,436 $14.77 p/Share
6,800 Reduced 1.08%
622,869 Common Stock
Jun 12 2025
SELL
Open market or private sale
$253,296 $14.92 p/Share
16,977 Reduced 2.63%
629,669 Common Stock
DK

David Krempa

Chief Business Officer
Deerpark, IL

Track Institutional and Insider Activities on ETON

Follow Eton Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ETON shares.

Notify only if

Insider Trading

Get notified when an Eton Pharmaceuticals, Inc. insider buys or sells ETON shares.

Notify only if

News

Receive news related to Eton Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ETON